Abstract
As the most common non-dermatologic malignancy affecting males in the Western world, and the second leading cause of male cancer-related deaths, the importance of prostate cancer research needs little justification [1]. Epidemiologic reports have described the significant heritability of such malignancies, with one twin-study attributing 42 % (CI 29–50 %) of prostate cancer cases to heritable factors [2]. Genome-wide linkage analyses of germline single nucleotide polymorphisms (SNPs) continue to uncover many low-risk genetic associations with prostate cancer [3]. These findings are being supplemented with expression arrays in an effort to identify individual somatic mutations such as TMPRSS2-ERG gene fusions [4] as well as more global gene expression profiles.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277.
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85.
Witte J. Prostate cancer genomics: toward a new understanding. Nat Rev Genet. 2009;10(2):77–82.
Setlur SR, et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst. 2008;100:815–25.
Zheng SL, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med. 2008;358:910–9.
Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. Nat Rev Cancer. 2008;8:497–511.
Tewari AK, Rao S, Martinez-Salamanca JI, Leung R, Ramanathan R, Mandhani A, Vaughan ED, Menon M, Horninger W, Tu J, Bartsch G. Cancer control and the preservation of neurovascular tissue: how to meet competing goals during robotic radical prostatectomy. BJU Int. 2008;101(8):1013–8.
Hollenbeck BK, Bassily N, Wei JT, Montie JE, Hayasaka S, Taylor JM, Rubin MA. Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features. J Urol. 2000;164(5):1583–6.
Dev H, Rickman D, Sooriakumaran P, Srivastava A, Grover S, Leung R, Kim R, Kitabayashi N, Esqueva R, Park K, Padilla J, Rubin M, Tewari A. Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies. Prostate Cancer Prostatic Dis. J Transl Med. 2011 Jul 26;9:121.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Dev, H., Sooriakumaran, P., Tewari, A.K. (2013). Prostate Tissue Banking. In: Tewari, A. (eds) Prostate Cancer: A Comprehensive Perspective. Springer, London. https://doi.org/10.1007/978-1-4471-2864-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2864-9_16
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2863-2
Online ISBN: 978-1-4471-2864-9
eBook Packages: MedicineMedicine (R0)